CLARIANT AG-REG (CLRN.DE) Stock Fundamental Analysis
FRA:CLRN - CH0012142631 - Common Stock
8.88 EUR
-0.04 (-0.45%)
Taking everything into account, CLRN scores 5 out of 10 in our fundamental rating. CLRN was compared to 70 industry peers in the Chemicals industry. While CLRN is still in line with the averages on profitability rating, there are concerns on its financial health. CLRN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CLRN was profitable.
In the past year CLRN had a positive cash flow from operations.
CLRN had positive earnings in each of the past 5 years.
Each year in the past 5 years CLRN had a positive operating cash flow.
1.2 Ratios
CLRN's Return On Assets of 1.94% is in line compared to the rest of the industry. CLRN outperforms 58.57% of its industry peers.
CLRN has a Return On Equity (5.91%) which is comparable to the rest of the industry.
The Return On Invested Capital of CLRN (8.53%) is better than 72.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLRN is above the industry average of 6.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.94% | ||
| ROE | 5.91% | ||
| ROIC | 8.53% |
ROA(3y)2.59%
ROA(5y)4.79%
ROE(3y)6.89%
ROE(5y)14.05%
ROIC(3y)9.12%
ROIC(5y)8.14%
1.3 Margins
With a Profit Margin value of 2.78%, CLRN perfoms like the industry average, outperforming 58.57% of the companies in the same industry.
In the last couple of years the Profit Margin of CLRN has grown nicely.
CLRN's Operating Margin of 10.34% is fine compared to the rest of the industry. CLRN outperforms 71.43% of its industry peers.
CLRN's Operating Margin has been stable in the last couple of years.
CLRN's Gross Margin of 31.80% is in line compared to the rest of the industry. CLRN outperforms 45.71% of its industry peers.
CLRN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.34% | ||
| PM (TTM) | 2.78% | ||
| GM | 31.8% |
OM growth 3Y-1.74%
OM growth 5Y1.06%
PM growth 3Y-9.27%
PM growth 5Y91.64%
GM growth 3Y1.45%
GM growth 5Y-0.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLRN is creating some value.
The number of shares outstanding for CLRN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CLRN has less shares outstanding
The debt/assets ratio for CLRN is higher compared to a year ago.
2.2 Solvency
CLRN has an Altman-Z score of 2.20. This is not the best score and indicates that CLRN is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.20, CLRN perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
CLRN has a debt to FCF ratio of 9.10. This is a negative value and a sign of low solvency as CLRN would need 9.10 years to pay back of all of its debts.
CLRN's Debt to FCF ratio of 9.10 is fine compared to the rest of the industry. CLRN outperforms 65.71% of its industry peers.
CLRN has a Debt/Equity ratio of 0.78. This is a neutral value indicating CLRN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.78, CLRN is doing worse than 67.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 9.1 | ||
| Altman-Z | 2.2 |
ROIC/WACC1.67
WACC5.1%
2.3 Liquidity
A Current Ratio of 1.36 indicates that CLRN should not have too much problems paying its short term obligations.
CLRN has a worse Current ratio (1.36) than 74.29% of its industry peers.
CLRN has a Quick Ratio of 1.36. This is a bad value and indicates that CLRN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, CLRN is doing worse than 68.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
CLRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.04%, which is quite impressive.
Measured over the past years, CLRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 89.79% on average per year.
Looking at the last year, CLRN shows a decrease in Revenue. The Revenue has decreased by -2.40% in the last year.
CLRN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.15% yearly.
EPS 1Y (TTM)34.04%
EPS 3Y-10.78%
EPS 5Y89.79%
EPS Q2Q%-83.42%
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y-1.71%
Revenue growth 5Y-1.15%
Sales Q2Q%-53.24%
3.2 Future
CLRN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.50% yearly.
The Revenue is expected to grow by 2.79% on average over the next years.
EPS Next Y-8.23%
EPS Next 2Y5.11%
EPS Next 3Y8.08%
EPS Next 5Y4.5%
Revenue Next Year-2.56%
Revenue Next 2Y0.48%
Revenue Next 3Y1.61%
Revenue Next 5Y2.79%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.00, CLRN is valued on the expensive side.
CLRN's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.08, CLRN is valued at the same level.
CLRN is valuated reasonably with a Price/Forward Earnings ratio of 8.99.
Based on the Price/Forward Earnings ratio, CLRN is valued cheaply inside the industry as 95.71% of the companies are valued more expensively.
CLRN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24 | ||
| Fwd PE | 8.99 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLRN is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
87.14% of the companies in the same industry are more expensive than CLRN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.27 | ||
| EV/EBITDA | 6.3 |
4.3 Compensation for Growth
The decent profitability rating of CLRN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2Y5.11%
EPS Next 3Y8.08%
5. Dividend
5.1 Amount
CLRN has a Yearly Dividend Yield of 5.04%, which is a nice return.
Compared to an average industry Dividend Yield of 3.08, CLRN pays a better dividend. On top of this CLRN pays more dividend than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, CLRN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.04% |
5.2 History
The dividend of CLRN decreases each year by -5.09%.
Dividend Growth(5Y)-5.09%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
123.01% of the earnings are spent on dividend by CLRN. This is not a sustainable payout ratio.
DP123.01%
EPS Next 2Y5.11%
EPS Next 3Y8.08%
FRA:CLRN (8/28/2025, 7:00:00 PM)
8.88
-0.04 (-0.45%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners56.33%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap2.95B
Analysts73.64
Price Target12.39 (39.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.04% |
Yearly Dividend0.45
Dividend Growth(5Y)-5.09%
DP123.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.1%
PT rev (3m)-7.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12.81%
EPS NY rev (3m)-12.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.31%
Revenue NY rev (3m)-3.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24 | ||
| Fwd PE | 8.99 | ||
| P/S | 0.68 | ||
| P/FCF | 12.27 | ||
| P/OCF | 6.54 | ||
| P/B | 1.44 | ||
| P/tB | 6.7 | ||
| EV/EBITDA | 6.3 |
EPS(TTM)0.37
EY4.17%
EPS(NY)0.99
Fwd EY11.12%
FCF(TTM)0.72
FCFY8.15%
OCF(TTM)1.36
OCFY15.29%
SpS13.07
BVpS6.15
TBVpS1.33
PEG (NY)N/A
PEG (5Y)0.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.94% | ||
| ROE | 5.91% | ||
| ROCE | 9.85% | ||
| ROIC | 8.53% | ||
| ROICexc | 9.54% | ||
| ROICexgc | 15.71% | ||
| OM | 10.34% | ||
| PM (TTM) | 2.78% | ||
| GM | 31.8% | ||
| FCFM | 5.54% |
ROA(3y)2.59%
ROA(5y)4.79%
ROE(3y)6.89%
ROE(5y)14.05%
ROIC(3y)9.12%
ROIC(5y)8.14%
ROICexc(3y)10.63%
ROICexc(5y)9.45%
ROICexgc(3y)15.35%
ROICexgc(5y)13.55%
ROCE(3y)10.52%
ROCE(5y)9.41%
ROICexcg growth 3Y0.58%
ROICexcg growth 5Y6.23%
ROICexc growth 3Y-3.64%
ROICexc growth 5Y2.78%
OM growth 3Y-1.74%
OM growth 5Y1.06%
PM growth 3Y-9.27%
PM growth 5Y91.64%
GM growth 3Y1.45%
GM growth 5Y-0.24%
F-Score8
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 9.1 | ||
| Debt/EBITDA | 2.23 | ||
| Cap/Depr | 78.49% | ||
| Cap/Sales | 4.85% | ||
| Interest Coverage | 5.75 | ||
| Cash Conversion | 62.89% | ||
| Profit Quality | 199.12% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 2.2 |
F-Score8
WACC5.1%
ROIC/WACC1.67
Cap/Depr(3y)83.05%
Cap/Depr(5y)99.02%
Cap/Sales(3y)4.61%
Cap/Sales(5y)5.96%
Profit Quality(3y)196.87%
Profit Quality(5y)120.08%
High Growth Momentum
Growth
EPS 1Y (TTM)34.04%
EPS 3Y-10.78%
EPS 5Y89.79%
EPS Q2Q%-83.42%
EPS Next Y-8.23%
EPS Next 2Y5.11%
EPS Next 3Y8.08%
EPS Next 5Y4.5%
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y-1.71%
Revenue growth 5Y-1.15%
Sales Q2Q%-53.24%
Revenue Next Year-2.56%
Revenue Next 2Y0.48%
Revenue Next 3Y1.61%
Revenue Next 5Y2.79%
EBIT growth 1Y7.69%
EBIT growth 3Y-3.42%
EBIT growth 5Y-0.1%
EBIT Next Year62.33%
EBIT Next 3Y24.37%
EBIT Next 5Y14.31%
FCF growth 1Y-43.61%
FCF growth 3Y311.47%
FCF growth 5Y-1.02%
OCF growth 1Y-29.31%
OCF growth 3Y4.81%
OCF growth 5Y-3.86%